Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Science Advances|December 19, 2025
Interleukin-2 is a potent latency reversal agent in people with treated HIV-1Michael L Freeman, Brian M Clagett, Konstantin Leskov, et al.
Journal of Molecular Biology|February 6, 2004
Rational design of inhibitors of HIV-1 TAR RNA through the stabilisation of electrostatic "hot spots"Ben Davis, Mohammad Afshar, Gabriele Varani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 2021
Sex Differences in Human Immunodeficiency Virus Persistence and Reservoir Size During AgingSara Gianella, Stephen A Rawlings, Curtis Dobrowolski, et al.
Open Forum Infectious Diseases|January 15, 2026
Longitudinal T-Cell Phenotypic Dynamics During Sustained Antiretroviral Therapy in People With HIVChristophe Vanpouille, Alan Wells, Victor DeGruttola, et al.
Cell Reports|February 15, 2023
Genomic profiling of HIV-1 integration in microglia cells links viral integration to the topologically associated domainsMona Rheinberger, Ana Luisa Costa, Martin Kampmann, et al.
Journal of Molecular Biology|April 21, 2004
Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNAAlastair I H Murchie, Ben Davis, Catherine Isel, et al.
Nature Communications|June 9, 2023
A viral pan-end RNA element and host complex define a SARS-CoV-2 regulonDebjit Khan, Fulvia Terenzi, GuanQun Liu, et al.
Pageof 8